Grants and Contributions:
Title:
MDAP 2025 – Market Diversification Action Plan
Agreement Number:
1034157
Agreement Value:
$50,000.00
Agreement Date:
Sep 1, 2025 - Feb 28, 2026
Description:
The firm is targeting early adopter customers who value modernized treatment solutions, prefer Western/European medical devices, and are open to piloting the firm's products in clinical settings. Vietnam (Hanoi) is the firm's first choice due to strong ties with the national hospital network, their familiarity with oncology QA devices, and growing demand for advanced patient positioning. Many hospitals seek higher-quality alternatives to lower-grade imports from China, and the firm's LT-Thermoplastics and system devices deliver the reliability and performance they need.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Calgary, Alberta, CA T2C 0J6
Reference Number:
172-2025-2026-Q2-1034157
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
860194133
Recipient Type:
For-profit organization
Recipient's Legal Name:
CDR Systems Inc.
Federal Riding Name:
Calgary Shepard
Federal Riding Number:
48011
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
339110